Press Release

Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Braintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesBraintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesEducation Secretary joins Cell and Gene Therapy Catapult to celebrate apprenticesEducation Secretary joins Cell and Gene Therapy Catapult to celebrate apprenticesUK maintains its position as an attractive destination for advanced therapy clinical trialsUK maintains its position as an attractive destination for advanced therapy clinical trialsCell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sectorCell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sectorLeading industry surveys demonstrate continued growth in the UK’s cell and gene therapy sectorLeading industry surveys demonstrate continued growth in the UK’s cell and gene therapy sectorCell and Gene Therapy Catapult focuses on strategic areas to further unlock the full potential of the UK advanced therapy industryCell and Gene Therapy Catapult focuses on strategic areas to further unlock the full potential of the UK advanced therapy industryCryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesCryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesCell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerCell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business Officer